Clinical Trial Update: Comparison of Intralase and Visumax Femtosecond Laser for Laser In Situ Keratomileusis

View source ↗

Summary

A completed clinical trial comparing Intralase and Visumax femtosecond laser systems for laser-assisted in situ keratomileusis in myopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Myopia | Status: COMPLETED